Li, Xiaoxi
Yu, Ling
Yang, Jiaonan
Fu, Miao
Tan, Hongyu
Article History
Received: 13 October 2023
Accepted: 23 May 2024
First Online: 28 May 2024
Declarations
:
: This study was approved by the Institutional Review Board at Peking University Cancer Hospital (No. 2023YJZ36). The requirement for written informed consent was waived because of the study’s retrospective design.
: Not applicable.
: The authors declare no competing interests.